Organ Transplant Diagnostics Market Analysis 2020 - Growth by Top Companies and Trends by Types, Treatment, Diagnosis and Application Forecast Analysis to 2024 with QIAGEN NV,Thermo Fisher Scientific

Organ Transplant Diagnostics market 2020 research report is a detailed view of market opportunity by end-user segments, product Type segments, sales channels, key countries. It also provides market credentials such as history, various development and trends, market overview, regional markets and also market competitors. The report estimates the performance of the key players by 2024 .

Global Organ Transplant Diagnostics Market Overview:

According to the Business industry reports the Organ Transplant Diagnostics Market is going to have a huge growth in the upcoming years by Geographical analysis, applications segmentations and End Use Industry.

The demand for Organ Transplant Diagnostics products is expected to grow mainly due to factors such as the increasing public-private funding for target research activities, the growing burden of infectious diseases, the increasing number of transplant procedures, and technological advancements in the field of transplant diagnostics.

In addition, increasing number of patients suffering from chronic diseases frequently leading to organ failure is creating an upsurge in demand for transplant procedures. Moreover, adoption of stem cell therapy and personalized medicine is escalating. As a result, demand for pre-procedure diagnostics is growing swiftly. Risks and complexities associated with organ transplants necessitate the need for improved and sophisticated diagnostic tools. Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/247012 .

The market has increased the interest of healthcare providers owing to various benefits existing by these tests to assess the feasibility of the organ transplant procedure. There have been significant technological advancements in transplant diagnostics to provide advanced diagnostics options for the management of organ transplant. The market is in a mature phase in the developed countries, while the emerging regions such as LAMEA and Asia-Pacific hold potential opportunities for transplant diagnostics.

Global Key Vendors:

Organ Transplant Diagnostics Market is moderately competitive and consists of several major players. In terms of market share, some of the major players currently dominate the market. The end-users demand is driven by safety and regulatory needs and the companies operating in the market are leveraging on strategic collaborative initiatives, to offer specialized solutions, to increase their market share and increase their profitability. The companies operating in the market are also into mergers and acquisitions of start-ups that help in improving the served market portfolio on Organ Transplant Diagnostics to strengthen their product capabilities. Among the prominent players involved in the Organ Transplant Diagnostics market, companies such

QIAGEN NV

Thermo Fisher Scientific

BioMrieuxSA

CareDx

Luminex Corporation

Dickinson and Company

Biofortuna

Product Type Segmentation

Molecular Assay Technologies

Non-molecular Assay Technologies

Industry Segmentation

Independent Reference Laboratories

Hospitals and Transplant Centers

Research Laboratories and Academic Institutes

Region related information

North America (US and Canada), Europe (Germany, France, UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, Japan, Australia, India, South Korea, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of LATAM), and the Middle East and Africa

Purchase this report online with 125 Pages, List of Tables & Figures and in-depth Table of Contents on "Global Organ Transplant Diagnostics Report 2020" @ https://www.businessindustryreports.com/buy-now/247012/single .

Global Industry News:

QIAGEN NV : QIAGEN launches FFPE and Liquid Biopsy PIK3CA diagnostics in Europe to enhance precision medicine in advanced breast cancer

QIAGEN N.V today announced the CE-marking and launch of its therascreen PIK3CA RGQ PCR Kit in Europe as an aid in identifying breast cancer patients with a PIK3CA mutation. Last year the therascreen PIK3CA test was approved by the FDA and launched as a companion diagnostic test for Piqray (alpelisib) in the US.

The therascreen PIK3CA test is a new diagnostic assay for detection of activating mutations in the phosphatidylinositol3-kinase catalytic subunit alpha (PIK3CA) gene, and the first to enable testing of both DNA from FFPE tissue or plasma specimens. All QIAGEN therascreen PIK3CA tests leverage QIAGEN's worldwide co-exclusive license from Johns Hopkins University for PCR-based companion diagnostics based on detection of mutations in the PIK3CA gene.

1 in 8 women in Europe will develop breast cancer before the age of 85, making it the most common form of cancer in female patients. The therascreen assay detects 11 clinically actionable PIK3CA mutations, which are estimated to be present in approximately 40% of hormone receptor-positive, human epidermal growth factor receptor-2 negative (HR+ HER2-) advanced breast cancer cases.

"This launch in Europe further underscores our commitment to support patients with breast cancer, the most common cancer in female cancer patients, with an estimated incidence of 562,500 in Europe in 2018 according to the WHO" said Jonathan Arnold, Vice President, Head of Oncology and Precision Diagnostics. "We are convinced that our therascreen PIK3CA Kit, which expands our market-leading therascreen portfolio of companion diagnostics, will provide a valuable testing option for those seeking new ways to combat advanced breast cancer. We are committed to making the therascreen PIK3CA Kit available immediately so that leading laboratories in Europe can provide patients with the test as soon as possible."

Highlights Of Report :

The report Organ Transplant Diagnostics market provides highlighting new business opportunities and supporting strategic and calculated decision-making. This report recognizes that in this rapidly-evolving and competitive environment, up-to-date marketing information is essential to monitor performance and make critical decisions for growth and profitability. It provides information on trends and developments and focuses on markets capacities and on the changing structure of the Organ Transplant Diagnostics . The report highlights powerful factors augmenting the demand in the global Organ Transplant Diagnostics market and even those hampering the market on a worldwide scale. The report provides key statistics on the market status of the Organ Transplant Diagnostics leading manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.

Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/247012 .

Major Points in Table of Contents:

Global Organ Transplant Diagnostics Market Report 2020

Section 1 Organ Transplant Diagnostics Product Definition

Section 2 Global Organ Transplant Diagnostics Market Manufacturer Share and Market Overview

2.1 Global Manufacturer Organ Transplant Diagnostics Shipments

2.2 Global Manufacturer Organ Transplant Diagnostics Business Revenue

2.3 Global Organ Transplant Diagnostics Market Overview

Section 3 Manufacturer Organ Transplant Diagnostics Business Introduction

3.1 QIAGEN NV Organ Transplant Diagnostics Business Introduction

3.1.1 QIAGEN NV Organ Transplant Diagnostics Shipments, Price, Revenue and Gross profit 2014-2019

3.1.2 QIAGEN NV Organ Transplant Diagnostics Business Distribution by Region

3.1.3 QIAGEN NV Interview Record

3.1.4 QIAGEN NV Organ Transplant Diagnostics Business Profile

3.1.5 QIAGEN NV Organ Transplant Diagnostics Product Specification

3.2 Thermo Fisher Scientific Organ Transplant Diagnostics Business Introduction

3.2.1 Thermo Fisher Scientific Organ Transplant Diagnostics Shipments, Price, Revenue and Gross profit 2014-2019

3.2.2 Thermo Fisher Scientific Organ Transplant Diagnostics Business Distribution by Region

3.2.3 Interview Record

3.2.4 Thermo Fisher Scientific Organ Transplant Diagnostics Business Overview

3.2.5 Thermo Fisher Scientific Organ Transplant Diagnostics Product Specification

3.3 BioMrieuxSA Organ Transplant Diagnostics Business Introduction

3.3.1 BioMrieuxSA Organ Transplant Diagnostics Shipments, Price, Revenue and Gross profit 2014-2019

3.3.2 BioMrieuxSA Organ Transplant Diagnostics Business Distribution by Region

3.3.3 Interview Record

3.3.4 BioMrieuxSA Organ Transplant Diagnostics Business Overview

3.3.5 BioMrieuxSA Organ Transplant Diagnostics Product Specification

3.4 CareDx Organ Transplant Diagnostics Business Introduction

3.5 Luminex Corporation Organ Transplant Diagnostics Business Introduction

3.6 Dickinson and Company Organ Transplant Diagnostics Business Introduction................... Request free sample to get a complete Table of Content

About us

BusinessindustryReports.com is digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined - we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune - India

sales@businessindustryreports.com

+19376349940

This release was published on openPR.